Although the relation between androgens and adolescent risk-taking has been relatively well documented in boys, little is known as to how sex steroid hormones relate to aggressive (ART) and/or non-aggressive adolescent risk-taking (NART) behavior in girls. On the basis of a sample of 298 adolescent girls (mean age: 14.3 years), we examined: (i) the relationship between serum levels of testosterone (T) and estradiol (E2) in relation to ART and NART and (ii) if differential association--having friends who are highly involved in risk-taking--moderates the relationship between relationships between hormones and risk-taking. The sample provided evidence of an association between free estradiol (FE2) and both NART (Beta=0.19; p<0.01) and ART (Beta=0.19; p<0.01), controlling for age and pubertal development. No relationship between T and ART or NART was found. The importance of the relationship between E2 and ART and NART differed between girls at different phases of their menstrual cycle and was significant only for girls in the mid-phase of the menstrual cycle. In addition, significant interactions between differential association and FE2 were found indicating that the relationship between FE2 and NART and ART was particularly strong in girls with high levels of differential association.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.psyneuen.2008.03.016 | DOI Listing |
Schizophr Bull
January 2025
Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Background And Hypothesis: Improvements in screening tools for early subthreshold psychosis symptoms are needed to facilitate early identification and intervention efforts, especially given the challenges of rapidly differentiating age-appropriate experiences from potential early signs of emerging psychosis. Tools can be lengthy and time-consuming, impacting their utility and accessibility across clinical settings, and age-normed data are limited. To address this gap, we sought to develop and validate a brief, empirically derived, age-normed, subthreshold psychosis screening tool, for public use.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands.
Importance: Preventive efforts in pregnancy-related alloimmunization have considerably decreased the prevalence of hemolytic disease of the fetus and newborn (HDFN). International studies are therefore essential to obtain a deeper understanding of the postnatal management and outcomes of HDFN. Taken together with numerous treatment options, large practice variations among centers may exist.
View Article and Find Full Text PDFArch Womens Ment Health
January 2025
Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, JP Winsløw Vej 21, Odense, DK - 5000, Denmark.
Purpose: Infertility is common and an increasing number of women go through medically assisted reproduction (fertility treatment) to achieve pregnancy. This may affect mental health. We examined if fertility treatment and the specific fertility treatment method used (in vivo or in vitro) were associated with impaired mental health during or after pregnancy.
View Article and Find Full Text PDFEur Child Adolesc Psychiatry
January 2025
Department of Psychiatry, Neurology, Psychotherapy and Psychosomatics in Childhood and Adolescence, Rostock University Medical Center, Gehlsheimer Straße 20, 18147, Rostock, Germany.
Transcranial direct current stimulation (tDCS) remains experimental for many psychiatric disorders in adults. Particularly in childhood, there is limited research on the evidence for the efficacy and mechanisms of action of tDCS on the developing brain. The objective of this review is to identify published experimental studies to examine the efficacy and mechanisms of tDCS in children with psychiatric or developmental disorders in early (prepubertal) childhood (aged under 10 years).
View Article and Find Full Text PDFAnn Hematol
January 2025
Department of Research, Medical Research Circle, Goma, 73 Gisenyi, Democratic Republic of the Congo.
T-cell Acute Lymphoblastic Leukemia (T-ALL) is a subtype of acute lymphoblastic leukemia characterized by the proliferation of abnormal T-cell precursors. Nelarabine, a purine analog, has been approved as a targeted therapy for patients with refractory or relapsed T-ALL. This study aims to evaluate the efficacy and safety of Nelarabine, either as monotherapy or in combination with other therapies, in treating T-ALL.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!